Therapeutic Targeting of Oncogenes

癌基因的治疗靶向

• 批准号: nhmrc : GNT1106576
• 负责人: Prof Grant McArthur
• 金额: $ 85.2万
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2016
• 资助国家: 澳大利亚
• 起止时间: 2016-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/therapeutic-targeting-oncogenes/1346523
• 关键词: Therapeutic; Targeting; Oncogenes

Treatments that target cancer causing genes called oncogenes have resulted in new treatment paradigms for cancer. We suggest that outcomes of patients with cancer will be further substantially improved by understanding how cancers can overcome resistance to these treatments that develops in many patients. To accelerate the adoption of these and other new treatments for cancer we will also develop new frameworks for clinical trials.

针对致癌基因的治疗已经产生了新的癌症治疗模式。我们建议，通过了解癌症如何克服在许多患者中出现的对这些治疗的耐药性，癌症患者的预后将进一步得到实质性改善。为了加速采用这些和其他新的癌症治疗方法，我们还将制定新的临床试验框架。